Home/Filings/4/0001235802-20-000063
4//SEC Filing

Smith Kevin C. 4

Accession 0001235802-20-000063

CIK 0001492658other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 5:07 PM ET

Size

5.4 KB

Accession

0001235802-20-000063

Insider Transaction Report

Form 4
Period: 2020-06-02
Smith Kevin C.
SVP, Quality and Regulatory
Transactions
  • Sale

    Ordinary Shares, par value EUR 0.03 per share

    2020-06-02$29.68/sh687$20,39117,183 total
Footnotes (2)
  • [F1]These shares were sold under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, to cover the estimated tax withholding obligations in connection with the vesting of restricted stock units.
  • [F2]Includes 5,272 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 4,185 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.

Issuer

Wright Medical Group N.V.

CIK 0001492658

Entity typeother

Related Parties

1
  • filerCIK 0001734572

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:07 PM ET
Size
5.4 KB